Genome & Company (KOSDAQ:314130)
2,560.00
-70.00 (-2.66%)
At close: Aug 28, 2025
-2.66% (1Y)
Market Cap | 79.58B |
Revenue (ttm) | 24.02B |
Net Income (ttm) | -27.08B |
Shares Out | 31.09M |
EPS (ttm) | -875.69 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 63,775 |
Average Volume | 95,703 |
Open | 2,630.00 |
Previous Close | 2,630.00 |
Day's Range | 2,520.00 - 2,645.00 |
52-Week Range | 2,170.00 - 4,900.00 |
Beta | 1.13 |
RSI | 42.85 |
Earnings Date | Aug 14, 2025 |